Company: SPRB
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-059288
Chunk: 22

Company: SPRUCE BIOSCIENCES, INC.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 22
---
 Board on significant items and discussions between the CEO and our Chair of the Board on a periodic basis. Each director is expected to and does bring to bear their own talents, insights, and experiences to these strategy discussions.

The Board met eleven times during the last fiscal year. All directors, except Dr. Muralidhar, attended at least 75% of the aggregate number of meetings of the Board and of the committees on which they served, held during the portion of the last fiscal year for which they were directors or committee members, respectively.

In 2024, the Company’s non-employee directors met four times in regularly scheduled executive sessions at which only non-employee directors were present.

Board Composition

We believe that our directors collectively have an appropriate balance of knowledge, experience, attributes, skills and expertise to ensure that the Board appropriately fulfills its oversight responsibilities and acts in the best interests of our stockholders. Although specific qualifications for membership on the Board may vary from time to time, desired qualities include (A) the highest personal integrity and ethics, (B) relevant expertise upon which to be able to offer advice and guidance to management, (C) demonstrated excellence in his or her field, (D) sound business judgment, (E) sufficient time to devote to the affairs of the Company, and (F) commitment to rigorously represent the long-term interests of our stockholders.

<div align='center'>13</div>

The following table depicts the key skills and experience that we consider important in light of our current business structure and that our directors bring to our company.

|                              | T. Aynechi | P. Barretto-Ko | M. Grey | B. Muralidhar | C. Simpson | D. Spiegelman | J. Szwarcberg | K. Ways |
| Financial and Accounting     |            |                | ●       | ●             |            | ●             |               |         |
| Senior Leadership            | ●          | ●              | ●       | ●             | ●          | ●             | ●             | ●       |
| Healthcare                   | ●          | ●              | ●       | ●             | ●          | ●             | ●             | ●       |
| Research and Development     | ●          | ●              | ●       |               | ●          |               | ●             | ●       |
| Commercial                   |            | ●              | ●       |               |            |               |               |         |
| Governance                   | ●          |                | ●       | ●